{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:37:45Z","timestamp":1780447065355,"version":"3.54.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T00:00:00Z","timestamp":1565654400000},"content-version":"vor","delay-in-days":224,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003970","name":"Isfahan University of Medical Sciences","doi-asserted-by":"publisher","award":["394608"],"award-info":[{"award-number":["394608"]}],"id":[{"id":"10.13039\/501100003970","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research Reports"],"published-print":{"date-parts":[[2019]]},"DOI":"10.1016\/j.lrr.2019.100181","type":"journal-article","created":{"date-parts":[[2019,8,14]],"date-time":"2019-08-14T02:11:50Z","timestamp":1565748710000},"page":"100181","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Prognostic significance of Fc receptor-like 1 in patients with chronic lymphocytic leukemia, hairy cell leukemia, and various B-cell non-Hodgkin's lymphoma"],"prefix":"10.1016","volume":"12","author":[{"given":"Zahra","family":"Yousefi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahid","family":"Eskandari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lrr.2019.100181_bib0001","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0140-6736(16)32407-2","article-title":"Non-Hodgkin lymphoma","volume":"390","author":"Armitage","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.lrr.2019.100181_bib0002","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2147\/CMAR.S34273","article-title":"Treatment challenges in the management of relapsed or refractory non-Hodgkin's lymphoma\u2013novel and emerging therapies","volume":"5","author":"Chao","year":"2013","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.lrr.2019.100181_bib0003","series-title":"Introduction to a Review Series: The Paradox of Indolent B-Cell Lymphoma","author":"Sehn","year":"2016"},{"key":"10.1016\/j.lrr.2019.100181_bib0004","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/sj.leu.2404445","article-title":"Elevation of soluble CD307 (IRTA2\/FcRH5) protein in the blood and expression on malignant cells of patients with multiple myeloma, chronic lymphocytic leukemia, and mantle cell lymphoma","volume":"21","author":"Ise","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.lrr.2019.100181_bib0005","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/j.1365-2559.2012.04289.x","article-title":"IRTA1 is selectively expressed in nodal and extranodal marginal zone lymphomas","volume":"61","author":"Falini","year":"2012","journal-title":"Histopathology"},{"key":"10.1016\/j.lrr.2019.100181_bib0006","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1182\/blood-2008-01-131359","article-title":"FCRL2 expression predicts IGHV mutation status and clinical progression in chronic lymphocytic leukemia","volume":"112","author":"Li","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.lrr.2019.100181_bib0007","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1093\/intimm\/dxl069","article-title":"Expression pattern of the human FCRH\/IRTA receptors in normal tissue and in B-chronic lymphocytic leukemia","volume":"18","author":"Polson","year":"2006","journal-title":"Int. Immunol."},{"key":"10.1016\/j.lrr.2019.100181_bib0008","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1182\/blood-2007-07-102350","article-title":"FCRL1 on chronic lymphocytic leukemia, hairy cell leukemia, and B-cell non-Hodgkin lymphoma as a target of immunotoxins","volume":"111","author":"Du","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.lrr.2019.100181_bib0009","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1365-2141.2004.05193.x","article-title":"Expression pattern of FCRL (FREB, FCRX) in normal and neoplastic human B cells","volume":"127","author":"Masir","year":"2004","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.lrr.2019.100181_bib0010","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.4049\/jimmunol.143.9.3100","article-title":"Identification and characterization of a cell-surface molecule that is selectively induced on rat lymphokine-activated killer cells","volume":"143","author":"Imboden","year":"1989","journal-title":"J. Immunol."},{"key":"10.1016\/j.lrr.2019.100181_bib0011","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S1074-7613(01)00109-1","article-title":"IRTA1 and IRTA2, novel immunoglobulin superfamily receptors expressed in B cells and involved in chromosome 1q21 abnormalities in B cell malignancy","volume":"14","author":"Hatzivassiliou","year":"2001","journal-title":"Immunity"},{"key":"10.1016\/j.lrr.2019.100181_bib0012","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1182\/blood.V99.8.2662","article-title":"IRTAs: a new family of immunoglobulinlike receptors differentially expressed in B cells","volume":"99","author":"Miller","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.lrr.2019.100181_bib0013","doi-asserted-by":"crossref","first-page":"9772","DOI":"10.1073\/pnas.171308498","article-title":"Identification of a family of Fc receptor homologs with preferential B cell expression","volume":"98","author":"Davis","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lrr.2019.100181_bib0014","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1146\/annurev.immunol.25.022106.141541","article-title":"Fc receptor-like molecules","volume":"25","author":"Davis","year":"2007","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.lrr.2019.100181_bib0015","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1006\/bbrc.2000.4213","article-title":"Molecular cloning and characterization of SPAP1, an inhibitory receptor","volume":"280","author":"Xu","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lrr.2019.100181_bib0016","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1034\/j.1600-065X.2002.19009.x","article-title":"Fc receptor homologs: newest members of a remarkably diverse Fc receptor gene family","volume":"190","author":"Davis","year":"2002","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.lrr.2019.100181_bib0017","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0006-291X(02)00332-7","article-title":"SPAP2, an Ig family receptor containing both ITIMs and ITAMs","volume":"293","author":"Xu","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lrr.2019.100181_bib0018","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1006\/bbrc.2001.5231","article-title":"BXMAS1 identifies a cluster of homologous genes differentially expressed in B cells","volume":"285","author":"Nakayama","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lrr.2019.100181_bib0019","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s11008-005-0082-0","article-title":"Expression patterns of the human and mouse IFGP family genes","volume":"39","author":"Ershova","year":"2005","journal-title":"Mol. Biol."},{"key":"10.1016\/j.lrr.2019.100181_bib0020","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00251-002-0436-x","article-title":"A family of highly diverse human and mouse genes structurally links leukocyte FcR, gp42 and PECAM-1","volume":"54","author":"Guselnikov","year":"2002","journal-title":"Immunogenetics"},{"key":"10.1016\/j.lrr.2019.100181_bib0021","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/ni0506-431","article-title":"New nomenclature for Fc receptor\u2013like molecules","volume":"7","author":"Maltais","year":"2006","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.lrr.2019.100181_bib0022","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.imlet.2010.09.019","article-title":"New B-cell CD molecules","volume":"134","author":"Matesanz-Isabel","year":"2011","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.lrr.2019.100181_bib0023","series-title":"Negat. Co-Receptors Ligands","first-page":"89","article-title":"Immunoregulatory roles for Fc receptor-like molecules","author":"Ehrhardt","year":"2010"},{"key":"10.1016\/j.lrr.2019.100181_bib0024","first-page":"155","article-title":"Fc receptor \u2013 like proteins of B cell function","author":"Ehrhardt","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.lrr.2019.100181_bib0025","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1080\/14728222.2018.1472768","article-title":"Update on Fc receptor-like (FCRL) family: new immunoregulatory players in health and diseases","volume":"22","author":"Rostamzadeh","year":"2018","journal-title":"Expert Opin. Ther. Targets."},{"key":"10.1016\/j.lrr.2019.100181_bib0026","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1002\/eji.201243068","article-title":"FCRL 3 promotes TLR 9\u2010induced B\u2010cell activation and suppresses plasma cell differentiation","volume":"43","author":"Li","year":"2013","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.lrr.2019.100181_bib0027","doi-asserted-by":"crossref","first-page":"7518","DOI":"10.4049\/jimmunol.0802230","article-title":"Fc receptor-like 3 protein expressed on IL-2 nonresponsive subset of human regulatory T cells","volume":"182","author":"Nagata","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.lrr.2019.100181_bib0028","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.0903943","article-title":"Expression of the autoimmune susceptibility gene FcRL3 on human regulatory T cells is associated with dysfunction and high levels of programmed cell death-1","author":"Swainson","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.lrr.2019.100181_bib0029","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.1401803","article-title":"Coexpression of tigit and FCRL3 identifies Helios+ human memory regulatory T cells","author":"Bin Dhuban","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.lrr.2019.100181_bib0030","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.1182\/blood-2006-06-030023","article-title":"FcRL6, a new ITIM-bearing receptor on cytolytic cells, is broadly expressed by lymphocytes following HIV-1 infection","volume":"109","author":"Wilson","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.lrr.2019.100181_bib0031","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1002\/eji.200838516","article-title":"FCRL6 distinguishes mature cytotoxic lymphocytes and is upregulated in patients with B\u2010cell chronic lymphocytic leukemia","volume":"38","author":"Schreeder","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.lrr.2019.100181_bib0032","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1034\/j.1600-065X.2002.19009.x","article-title":"Fc receptor homologs: newest members of a remarkably diverse Fc receptor gene family","volume":"190","author":"Davis","year":"2002","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.lrr.2019.100181_bib0033","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/eji.200425886","article-title":"An extended family of Fc receptor relatives","volume":"35","author":"Davis","year":"2005","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.lrr.2019.100181_bib0034","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s00262-008-0589-z","article-title":"Low representation of Fc receptor-like 1\u20135 molecules in leukemic cells from Iranian patients with acute lymphoblastic leukemia","volume":"58","author":"Kazemi","year":"2009","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.lrr.2019.100181_bib0035","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1002\/ijc.23751","article-title":"Fc receptor\u2010like 1\u20135 molecules are similarly expressed in progressive and indolent clinical subtypes of B\u2010cell chronic lymphocytic leukemia","volume":"123","author":"Kazemi","year":"2008","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.lrr.2019.100181_bib0036","first-page":"341","article-title":"Identification of outcome predictors in diffuse large B-cell lymphoma. Immunohistochemical profiling of homogeneously treated de novo tumors with nodal presentation on tissue micro-arrays","volume":"90","author":"Zinzani","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.lrr.2019.100181_bib0037","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1158\/1078-0432.87.11.1","article-title":"Immunoglobulin superfamily receptor translocation associated 2 protein on lymphoma cell lines and hairy cell leukemia cells detected by novel monoclonal antibodies","volume":"11","author":"Ise","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lrr.2019.100181_bib0038","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1182\/blood-2005-09-3815","article-title":"Epstein-Barr virus nuclear antigen 2 induces FcRH5 expression through CBF1","volume":"107","author":"Mohan","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.lrr.2019.100181_bib0039","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1182\/blood-2004-06-2344","article-title":"FcRH1: an activation coreceptor on human B cells","volume":"105","author":"Leu","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.lrr.2019.100181_bib0040","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1590\/S0100-879X2012007500130","article-title":"Overexpression of Fc receptor-like 1 associated with B-cell activation during hepatitis B virus infection","volume":"45","author":"Wang","year":"2012","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.lrr.2019.100181_bib0041","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/cyto.b.20063","article-title":"Flow cytometric immunophenotypic profiles of mature gamma delta T\u2010cell malignancies involving peripheral blood and bone marrow","volume":"67","author":"Ahmad","year":"2005","journal-title":"Cytom. Part B Clin. Cytom. J. Int. Soc. Anal. Cytol"},{"key":"10.1016\/j.lrr.2019.100181_bib0042","first-page":"236","article-title":"US\u2010Canadian consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: data analysis and interpretation","volume":"30","author":"Borowitz","year":"1997","journal-title":"Cytom. J. Int. Soc. Anal. Cytol."},{"key":"10.1016\/j.lrr.2019.100181_bib0043","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/30.9.e36","article-title":"Relative expression software tool (REST\u00a9) for group-wise comparison and statistical analysis of relative expression results in real-time PCR","volume":"30","author":"Pfaffl","year":"2002","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.lrr.2019.100181_bib0044","series-title":"Rest 2009 Software User Guide","author":"Pfaffl","year":"2009"},{"key":"10.1016\/j.lrr.2019.100181_bib0045","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0165-4608(02)00861-0","article-title":"Interphase cytogenetic characterization of aberrations in the long arm of chromosome 1 in B-cell lymphoid malignancies","volume":"144","author":"Weng","year":"2003","journal-title":"Cancer Genet. Cytogenet."},{"key":"10.1016\/j.lrr.2019.100181_bib0046","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/gcc.10181","article-title":"Characterization of the recurrent translocation t (1; 1)(p36. 3; q21. 1\u20132) in non\u2010Hodgkin lymphoma by multicolor banding and fluorescence in situ hybridization analysis","volume":"36","author":"Lestou","year":"2003","journal-title":"Genes Chromosom. Cancer"},{"key":"10.1016\/j.lrr.2019.100181_bib0047","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/gcc.10022","article-title":"Genome\u2010wide search for loss of heterozygosity in Burkitt lymphoma cell lines","volume":"33","author":"Sobol","year":"2002","journal-title":"Genes Chromosom. Cancer"},{"key":"10.1016\/j.lrr.2019.100181_bib0048","series-title":"Fc Recept.","first-page":"29","article-title":"Emerging roles for the FCRL family members in lymphocyte biology and disease","author":"Li","year":"2014"},{"key":"10.1016\/j.lrr.2019.100181_bib0049","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature"}],"container-title":["Leukemia Research Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213048919300445?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213048919300445?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T01:08:16Z","timestamp":1761959296000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213048919300445"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":49,"alternative-id":["S2213048919300445"],"URL":"https:\/\/doi.org\/10.1016\/j.lrr.2019.100181","relation":{},"ISSN":["2213-0489"],"issn-type":[{"value":"2213-0489","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic significance of Fc receptor-like 1 in patients with chronic lymphocytic leukemia, hairy cell leukemia, and various B-cell non-Hodgkin's lymphoma","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lrr.2019.100181","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100181"}}